Trevor Mcgoldrick
Dundee, SCT, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Somatic BRCA1/2 mutations are associated with a similar survival advantage to their germline counterparts in tubo-ovarian high grade serous carcinoma.
Journal: European journal of cancer (Oxford, England : 1990)
Published: December 10, 2024
Divergent trajectories to structural diversity impact patient survival in high grade serous ovarian cancer.
Journal: Nature communications
Published: October 03, 2024
Peri-Tumoural Lipid Composition and Hypoxia for Early Immune Response to Neoadjuvant Chemotherapy in Breast Cancer.
Journal: International journal of molecular sciences
Published: August 04, 2024
Towards detection of early response in neoadjuvant chemotherapy of breast cancer using Bayesian intravoxel incoherent motion.
Journal: Frontiers in oncology
Published: August 14, 2023
Analysis of the Clinical Advancements for BRCA-Related Malignancies Highlights the Lack of Treatment Evidence for BRCA-Positive Male Breast Cancer.
Journal: Cancers
Published: May 20, 2022
Structural Variants at the BRCA1/2 Loci are a Common Source of Homologous Repair Deficiency in High-grade Serous Ovarian Carcinoma.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 20, 2020
Phased-array combination of 2D MRS for lipid composition quantification in patients with breast cancer.
Journal: Scientific reports
Published: December 16, 2019
Routine germline BRCA1 and BRCA2 testing in patients with ovarian carcinoma: analysis of the Scottish real-life experience.
Journal: BJOG : an international journal of obstetrics and gynaecology
Published: January 26, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026